Search
Search Results
-
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
785PDF: 2256Supplementary: 300Appendix: 249 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1860PDF: 503SUPPLEMENTARY MATERIAL: 295GRAPHICAL ABSTRACT: 261HTML: 9 -
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3288PDF: 500Appendix: 374HTML: 23 -
Lipoprotein(a): what clinicians need to know
214PDF: 513HTML: 23 -
-
-
Applicability of obesity clinical practice guidelines in low- and middle-income countries
975PDF: 512Appendix: 136HTML: 10 -
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025
11565PDF: 7690Appendix: 1039 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
734PDF: 181Supplementary: 145Appendix: 104HTML: 18 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
725PDF: 196Supplementary: 140Appendix: 109HTML: 20 -
Epidemiology of peripartum cardiomyopathy in Africa
2180PDF: 484HTML: 74 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
121PDF: 204Supplementary: 142HTML: 16 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1050pdf: 233Supplementary Material: 38HTML: 99 -
Evolving targets for heart failure: the journey so far
1964pdf: 303HTML: 4

